{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:47:26Z","timestamp":1790624846473,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":2263,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jpain.2017.02.434","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T12:31:24Z","timestamp":1488889884000},"page":"835-843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Lower Placebo Responses After Long-Term Exposure to Fibromyalgia Pain"],"prefix":"10.1016","volume":"18","author":[{"given":"Eva","family":"Kosek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelie","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Carville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Gracely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanke","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Petzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ingvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin B.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2017.02.434_bib1","doi-asserted-by":"crossref","first-page":"10410","DOI":"10.1523\/JNEUROSCI.2541-04.2004","article-title":"Chronic back pain is associated with decreased prefrontal and thalamic gray matter density","volume":"24","author":"Apkarian","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2017.02.434_bib2","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1523\/JNEUROSCI.3576-06.2006","article-title":"Chronic pain and the emotional brain: Specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain","volume":"26","author":"Baliki","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2017.02.434_bib3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jpain.2017.02.434_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1300\/J094v02n02_06","article-title":"Long term follow-up of fibromyalgia patients","volume":"2","author":"Bengtsson","year":"1994","journal-title":"J Musculoskelet Pain"},{"key":"10.1016\/j.jpain.2017.02.434_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pain.2005.08.027","article-title":"Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network","volume":"120","author":"Bingel","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2017.02.434_bib6","doi-asserted-by":"crossref","first-page":"70ra14","DOI":"10.1126\/scitranslmed.3001244","article-title":"The effect of treatment expectation on drug efficacy: Imaging the analgesic benefit of the opioid remifentanil","volume":"3","author":"Bingel","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jpain.2017.02.434_bib7","first-page":"728","article-title":"The fibromyalgia impact questionnaire: Development and validation","volume":"18","author":"Burckhardt","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpain.2017.02.434_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/02845710108559239","article-title":"The Coping Strategies Questionnaire \u2013 Swedish version: Evidence of reliability and validity in patients with fibromyalgia","volume":"30","author":"Burckhardt","year":"2001","journal-title":"Scand J Behav Ther"},{"key":"10.1016\/j.jpain.2017.02.434_bib9","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/hbm.23132","article-title":"Coordinate-based (ALE) meta-analysis of brain activation in patients with fibromyalgia","volume":"37","author":"Dehghan","year":"2016","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.jpain.2017.02.434_bib10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neuron.2009.07.014","article-title":"Activation of the opioidergic descending pain control system underlies placebo analgesia","volume":"63","author":"Eippert","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.jpain.2017.02.434_bib11","doi-asserted-by":"crossref","first-page":"17993","DOI":"10.1073\/pnas.1305050110","article-title":"Placebo improves pleasure and pain through opposite modulation of sensory processing","volume":"110","author":"Ellingsen","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpain.2017.02.434_bib12","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1186\/1756-0500-5-644","article-title":"Contextual and time dependent pain in fibromyalgia: An explorative study","volume":"5","author":"Fors","year":"2012","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jpain.2017.02.434_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/ard.61.3.247","article-title":"Weather and the pain in fibromyalgia: Are they related?","volume":"61","author":"Fors","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jpain.2017.02.434_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pain.2009.02.008","article-title":"Pain relief through expectation supersedes descending inhibitory deficits in fibromyalgia patients","volume":"145","author":"Goffaux","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2017.02.434_bib15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/art.10225","article-title":"Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia","volume":"46","author":"Gracely","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpain.2017.02.434_bib16","doi-asserted-by":"crossref","first-page":"10000","DOI":"10.1523\/JNEUROSCI.2849-07.2007","article-title":"Decreased central mu-opioid receptor availability in fibromyalgia","volume":"27","author":"Harris","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2017.02.434_bib17","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.pain.2011.01.050","article-title":"Systematic review: Placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy-magnitude and patient-related predictors","volume":"152","author":"Hauser","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2017.02.434_bib18","first-page":"78","article-title":"Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: Systematic review and meta-analysis","volume":"30","author":"Hauser","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jpain.2017.02.434_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmpt.2003.11.003","article-title":"Assessing the clinical significance of change scores recorded on subjective outcome measures","volume":"27","author":"Hurst","year":"2004","journal-title":"J Manipulative Physiol Ther"},{"key":"10.1016\/j.jpain.2017.02.434_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pain.2009.03.018","article-title":"Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain","volume":"144","author":"Jensen","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2017.02.434_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1744-8069-8-32","article-title":"Patients with fibromyalgia display less functional connectivity in the brain\u2019s pain inhibitory network","volume":"8","author":"Jensen","year":"2012","journal-title":"Mol Pain"},{"key":"10.1016\/j.jpain.2017.02.434_bib22","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jpain.2014.09.011","article-title":"Segregating the cerebral mechanisms of antidepressants and placebo in fibromyalgia","volume":"15","author":"Jensen","year":"2014","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2017.02.434_bib23","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1002\/art.38170","article-title":"Overlapping structural and functional brain changes in patients with long-term exposure to fibromyalgia pain","volume":"65","author":"Jensen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpain.2017.02.434_bib24","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.neubiorev.2013.09.006","article-title":"The sweetest pill to swallow: How patient neurobiology can be harnessed to maximise placebo effects","volume":"37","author":"Jubb","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jpain.2017.02.434_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pain.2004.12.032","article-title":"Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition","volume":"114","author":"Julien","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2017.02.434_bib26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cct.2008.02.002","article-title":"Do \u201cplacebo responders\u201d exist?","volume":"29","author":"Kaptchuk","year":"2008","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jpain.2017.02.434_bib27","doi-asserted-by":"crossref","first-page":"e94207","DOI":"10.1371\/journal.pone.0094207","article-title":"The influence of the patient-clinician relationship on healthcare outcomes: A systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Kelley","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2017.02.434_bib28","doi-asserted-by":"crossref","first-page":"e67485","DOI":"10.1371\/journal.pone.0067485","article-title":"Are all placebo effects equal? Placebo pills, sham acupuncture, cue conditioning and their association","volume":"8","author":"Kong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2017.02.434_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2340\/165019771993117124","article-title":"A comparison of pressure pain thresholds in different tissues and body regions. Long-term reliability of pressure algometry in healthy volunteers","volume":"25","author":"Kosek","year":"1993","journal-title":"Scand J Rehabil Med"},{"key":"10.1016\/j.jpain.2017.02.434_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3959(96)03295-2","article-title":"Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects","volume":"70","author":"Kosek","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2017.02.434_bib31","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.0098-07.2007","article-title":"Accelerated brain gray matter loss in fibromyalgia patients: Premature aging of the brain?","volume":"27","author":"Kuchinad","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2017.02.434_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00002508-199709000-00003","article-title":"Possible deficiencies of pain modulation in fibromyalgia","volume":"13","author":"Lautenbacher","year":"1997","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2017.02.434_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pain.2012.09.017","article-title":"Amygdala activity contributes to the dissociative effect of cannabis on pain perception","volume":"154","author":"Lee","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2017.02.434_bib34","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0140-6736(78)92762-9","article-title":"The mechanism of placebo analgesia","volume":"2","author":"Levine","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jpain.2017.02.434_bib35","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1002\/art.24070","article-title":"White and gray matter abnormalities in the brain of patients with fibromyalgia: A diffusion-tensor and volumetric imaging study","volume":"58","author":"Lutz","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpain.2017.02.434_bib36","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1212\/WNL.0b013e3181b8791a","article-title":"Gray matter changes related to chronic posttraumatic headache","volume":"73","author":"Obermann","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jpain.2017.02.434_bib37","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1126\/science.1067176","article-title":"Placebo and opioid analgesia\u2013 imaging a shared neuronal network","volume":"295","author":"Petrovic","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jpain.2017.02.434_bib38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.sjpain.2012.10.002","article-title":"Using fMRI to evaluate the effects of milnacipran on central pain processing in patients with fibromyalgia","volume":"4","author":"Petzke","year":"2013","journal-title":"Scand J Pain"},{"key":"10.1016\/j.jpain.2017.02.434_bib39","doi-asserted-by":"crossref","first-page":"e000146","DOI":"10.1136\/rmdopen-2015-000146","article-title":"Real-life assessment of the validity of Patient Global Impression of Change in fibromyalgia","volume":"1","author":"Rampakakis","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.jpain.2017.02.434_bib40","doi-asserted-by":"crossref","first-page":"13746","DOI":"10.1523\/JNEUROSCI.3687-09.2009","article-title":"Brain gray matter decrease in chronic pain is the consequence and not the cause of pain","volume":"29","author":"Rodriguez-Raecke","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2017.02.434_bib41","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/j.pain.0000000000000633","article-title":"Endogenous opioidergic dysregulation of pain in fibromyalgia: A PET and fMRI study","volume":"157","author":"Schrepf","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2017.02.434_bib42","series-title":"Manual For The State-Trait Anxiety Inventory (Form Y)","author":"Spielberger","year":"1983"},{"key":"10.1016\/j.jpain.2017.02.434_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3959(03)00073-3","article-title":"The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients","volume":"105","author":"Vase","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2017.02.434_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrn3976","article-title":"The neuroscience of placebo effects: Connecting context, learning and health","volume":"16","author":"Wager","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jpain.2017.02.434_bib45","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1126\/science.1093065","article-title":"Placebo-induced changes in FMRI in the anticipation and experience of pain","volume":"303","author":"Wager","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jpain.2017.02.434_bib46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.jpain.2017.02.434_bib47","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpain.2017.02.434_bib48","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1523\/JNEUROSCI.0439-05.2005","article-title":"Placebo effects mediated by endogenous opioid activity on mu-opioid receptors","volume":"25","author":"Zubieta","year":"2005","journal-title":"J Neurosci"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590017304881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590017304881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T03:16:31Z","timestamp":1750043791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590017304881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1526590017304881"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2017.02.434","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower Placebo Responses After Long-Term Exposure to Fibromyalgia Pain","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2017.02.434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc. on behalf of the American Pain Society.","name":"copyright","label":"Copyright"}]}}